» Articles » PMID: 28652595

Altered Brain Metabolic Connectivity at Multiscale Level in Early Parkinson's Disease

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jun 28
PMID 28652595
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

To explore the effects of PD pathology on brain connectivity, we characterized with an emergent computational approach the brain metabolic connectome using [18F]FDG-PET in early idiopathic PD patients. We applied whole-brain and pathology-based connectivity analyses, using sparse-inverse covariance estimation in thirty-four cognitively normal PD cases and thirty-four age-matched healthy subjects for comparisons. Further, we assessed high-order resting state networks by interregional correlation analysis. Whole-brain analysis revealed altered metabolic connectivity in PD, with local decreases in frontolateral cortex and cerebellum and increases in the basal ganglia. Widespread long-distance decreases were present within the frontolateral cortex as opposed to connectivity increases in posterior cortical regions, all suggestive of a global-scale connectivity reconfiguration. The pathology-based analyses revealed significant connectivity impairment in the nigrostriatal dopaminergic pathway and in the regions early affected by α-synuclein pathology. Notably, significant connectivity changes were present in several resting state networks especially in frontal regions. These findings expand previous imaging evidence of altered connectivity in cognitively stable PD patients by showing pathology-based connectivity changes and disease-specific metabolic architecture reconfiguration at multiple scale levels, from the earliest PD phases. These alterations go well beyond the known striato-cortical connectivity derangement supporting in vivo an extended neural vulnerability in the PD synucleinopathy.

Citing Articles

PET, SPECT, and MRI imaging for evaluation of Parkinson's disease.

Gujral J, Gandhi O, Singh S, Ahmed M, Ayubcha C, Werner T Am J Nucl Med Mol Imaging. 2025; 14(6):371-390.

PMID: 39840378 PMC: 11744359. DOI: 10.62347/AICM8774.


Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of F-FDG-PET with antipsychotic dose correction.

De Simone G, Iasevoli F, Barone A, Gaudieri V, Cuocolo A, Ciccarelli M Schizophrenia (Heidelb). 2024; 10(1):116.

PMID: 39702476 PMC: 11659424. DOI: 10.1038/s41537-024-00535-4.


Computational Neurosurgery in Deep Brain Stimulation.

Germann J, Venetucci Gouveia F, Beyn M, Elias G, Lozano A Adv Exp Med Biol. 2024; 1462:435-451.

PMID: 39523281 DOI: 10.1007/978-3-031-64892-2_26.


Connectivity based on glucose dynamics reveals exaggerated sensorimotor network coupling on subject-level in Parkinson's disease.

Ruppert-Junck M, Heinecke V, Librizzi D, Steidel K, Beckersjurgen M, Verburg F Eur J Nucl Med Mol Imaging. 2024; 51(12):3630-3642.

PMID: 38884774 PMC: 11445336. DOI: 10.1007/s00259-024-06796-6.


Tumors Affect the Metabolic Connectivity of the Human Brain Measured by 18 F-FDG PET.

Pasquini L, Jenabi M, Graham M, Peck K, Schoder H, Holodny A Clin Nucl Med. 2024; 49(9):822-829.

PMID: 38693648 PMC: 11300165. DOI: 10.1097/RLU.0000000000005227.


References
1.
Hughes A, Daniel S, Kilford L, Lees A . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. PMC: 1014720. DOI: 10.1136/jnnp.55.3.181. View

2.
Yao N, Chang R, Cheung C, Pang S, Lau K, Suckling J . The default mode network is disrupted in Parkinson's disease with visual hallucinations. Hum Brain Mapp. 2014; 35(11):5658-66. PMC: 4657500. DOI: 10.1002/hbm.22577. View

3.
Hurley M, Mash D, Jenner P . Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci. 2003; 18(9):2668-72. DOI: 10.1046/j.1460-9568.2003.02963.x. View

4.
Kehagia A, Barker R, Robbins T . Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener Dis. 2012; 11(2):79-92. PMC: 5079071. DOI: 10.1159/000341998. View

5.
Koch J, Bitow F, Haack J, dHedouville Z, Zhang J, Tonges L . Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons. Cell Death Dis. 2015; 6:e1811. PMC: 4650722. DOI: 10.1038/cddis.2015.169. View